[Use of Mabtera (rituximab) in treating patients with refractory courses of B-cell lymphoma, along with high-dose chemotherapy and autologous transplantation of hematopoietic stem cells]. / Primenenie mabtery (rituksimab) u bol'nykh refrakternym techeniem B-kletochnym limfom, poluchaiushchikh vysokodoznuiu khimoterapiiu s autologichenoi transplanttatsiei kletok-predshestvennits gemopoéza.
Ter Arkh
; 75(1): 65-8, 2003.
Article
em Ru
| MEDLINE
| ID: mdl-12652962
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Linfoma de Células B
/
Condicionamento Pré-Transplante
/
Transplante de Células-Tronco
/
Anticorpos Monoclonais
Limite:
Adolescent
/
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
Ru
Ano de publicação:
2003
Tipo de documento:
Article